References
- Yamada M, Hudson S, Tournay O, Bittenbenders S, Shane S S, Lange B, et al. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementary-determining region (CDRIII)-specific probes. Proc Natl Acad Sci USA 1989; 86: 5123–7
- Deane M, McCarthy K P, Wiedemann L M, Norton J D. An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia 1991; 5: 726–30
- Rovera G, Wasserman R, Yamada M. Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction. New Engl J Med 1991; 324: 774–35
- Stewart A K, Schwartz R S. Immunoglobulin V regions and the B cell. Blood 1994; 83: 1717–30
- McCarthy K P, Sloan J P, Widemann L M. Rapid method for distinguishing clonal from polyclonal B-cell populations in surgical biopsy specimens. J Clin Pathol 1990; 43: 429–32
- Wasserman R, Yamada M, Ito Y, Finger L R, Reichard B A, Shane S, et al. VH gene rearrangement can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 223–8
- Petroni D, Lasa A, Pastore C, Soler J, Baiget M, Nomdedeu J. Rapid sequencing protocol using microconcentrators. Trends Genet 1996; 12: 167–8
- Guerrasio A, Martinelli G, Saglio G, Rosso C, Zaccaria A, Rosti G, Testoni N, Ambrosetti A, Izzi T, Sessarego M, Frassoni F, Gasparini P, Chiamenti A, Di Bartolomeo P, Pignatti P F. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogenic bone marrow transplants. Leukemia 1992; 6: 507–12
- Martiat P, Maisin D, Philippe M, Ferrant A, Michaux J L, Cassiman J J, et al. Detection of residual BCR/ABL transcripts in chronic myeloid leukemia patients in complete remission using the polymerase chain reaction and nested primers. Br J Haematol 1990; 75: 355–9
- Cross C P, Hughes T P, Feng L, O'Shea P, Bungey J, Marks D I, et al. Minimal residual disease after bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute graf-versus-host disease and relapse. Br J Haematol 1993; 83
- Lo Coco F, Diverio D, Pandolfi P P, Biondi A, Rossi V, Avvisati G, et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437–8
- Morgan G J, Hughes T P, Janssen J WG, Gow J, Guo A-P, Goldman J M, et al. Polymerase chain reaction for detection of residual leukaemia. Lancet 1989; 1: 928–9
- Hughes T P, Morgan G J, Martiat P, Goldman J M. Detection of residual leukaemia after bone marrow transplantation for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874–8
- Roth M S, Antin J H, Ash R, Valeri T H, Gotlieb M, Silver S M, Ginsburg D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogenic bone marrow transplant for chronic myeloid leukemia. Blood 1992; 79: 276–82
- Cleary M L, Meeker T C, Levy S, Lee E, Trela M, Sklar J, Levy R. Clustering of extensive somatic mutation in the variable region of an immunoglobulin heavy chain gene from a human B-cell lymphoma. Cell 1986; 44: 97–106
- Willman C L, Griffith B B, Whittaker M. Molecular genetic approaches for the diagnosis of clonality in lymphoid neoplasms. Clin Lab Med 1990; 10: 119–49